Inflammatory Bowel Disease

A 35-year-old woman presented to the emergency department (ED) with vague abdominal complaints. The patient had a complex medical history that included diverticulosis and relapsing polychondritis. Initially, her polychondritis was limited to involvement of the ears and nose. Within the past few years, however, her polychondritis flares had been associated with progressive dyspnea, which prompted intermittent and then long-term use of high-dose oral corticosteroids.

Traveler's diarrhea (TD) occurs in persons traveling fromindustrialized countries to less developed regions of the world.Because of the growing ease of travel and an increasinglyglobalized economy, TD is becoming more common. Increasingantibiotic resistance among causative bacterial organisms andalso emergence of new pathogens are additional challenges inthe management of TD. Enterotoxigenic and enteroaggregativepathotypes of Escherichia coli are the principal causes of TD.This review discusses the epidemiology of these pathogens, aswell as elements of prevention, diagnosis, and management.[Infect Med. 2008;25:264-276]

MILWAUKEE -- A Clostridium difficile infection sharply increases the risk of death for patients with underlying inflammatory bowel disease, researchers here said.

abstract: Inflammatory bowel disease (IBD) can have a variety of extraintestinal manifestations, including pulmonary disease. Bronchial involvement is the most common, but other manifestations include upper airway disease; parenchymal involvement, such as bronchiolitis obliterans with organizing pneumonia (BOOP) and interstitial lung disease; and serositis, including pleural effusions and pericarditis. Patients with BOOP may present with fever, dyspnea, cough, and pleuritic chest pain. Chest radiographs show bilateral patchy airspace opacities or a diffuse process; CT scans often demonstrate the opacities to be pleural-based. Corticosteroids appear to be effective in the management of certain pulmonary manifestations of IBD, such as BOOP and pulmonary infiltrates with eosinophilia. (J Respir Dis. 2007;28(6):227-234)

ABSTRACT: Screening options for colorectal cancer (CRC) include colonoscopy every 10 years, annual fecal occult blood testing, flexible sigmoidoscopy every 5 years, or double contrast barium enema every 5 years. In white patients at average risk, screening should begin at age 50; in African American patients, at age 45. Colonoscopy is preferred to sigmoidoscopy because it can detect proximal neoplasms and has the longest protection interval. High-risk patients include those with a family history of CRC or adenomas. These persons should begin colonoscopic screening at age 40, or 10 years earlier than the age at which CRC or adenomas were diagnosed in a first-degree relative. Other high-risk patients are those with a personal history of CRC, a genetic syndrome, or inflammatory bowel disease. In patients with CRC, the first follow-up colonoscopy is performed 1 year after surgery. If results are normal, the interval can be extended to every 3 years.

As the population ages, physicians are seeing a greaternumber of patients with colorectal disorders. This book combinesan up-to-date survey of the latest basic and clinicalresearch in the field with practical advice for the day-to-daycare of patients with colonic diseases. The first section ofthe book covers current knowledge of normal colorectal physiology.Section 2 discusses the basic disease mechanismsinvolved in colonic disorders and reviews the uses of suchinvestigational tools as colonoscopy, colonic biopsy, anorectalmanometry, ultrasonography, motility measurement,defecography, CT, and MRI. The third section offers a fulldiscussion of the diagnosis and treatment of commoncolonic disorders, including colorectal neoplasia, inflammatorybowel disease, ulcerative colitis, diverticular disease,Crohn disease, constipation, and irritable bowel syndrome.In addition to currently recommended approaches to evaluationand treatment, chapters in this section include discussionof advanced and investigational therapies.

A 40-year-old man has had discomfort at the distal end of thefingers of both hands for several weeks. He has also noticed nail pitting andonycholysis. He denies any trauma or inciting event and has been otherwisehealthy. He has no family history of inflammatory bowel disease, althoughhe believes that some family members have had rashes.

LONDON -- Inflammatory bowel disease roughly doubles a woman's risk of having a premature or a low-birth-weight child, according to a meta-analysis.

WINNIPEG, Manitoba -- Canadians from coast to coast are remarkably prone to inflammatory bowel disease, possibly the result of a climate that discourages bacterial activity and promotes sterile conditions in childhood.

Five days after beginning aggressive treatment with intravenous corticosteroids for inflammatory bowel disease, this 26-year-old man noticed the sudden eruption of this mildly pruritic rash.

A 53-year-old woman had complained of pain in the lower right quadrant of her abdomen for 1 year. She claimed that the pain intensified when she bent forward in a particular position but believed it was unrelated to food, bowel movements, or urination. There was no weight loss, vomiting, or melena. There was no family history of colon cancer or inflammatory bowel disease.

Adhesions can form within the peritoneal cavity after abdominal surgery, especially if there is an underlying inflammatory condition such as appendicitis or inflammatory bowel disease. The incidence of adhesive intestinal obstruction following a laparotomy is approximately 2%. Most adhesive obstructions occur within 3 months of the laparotomy, and 80% occur within 2 years. Adhesive obstructions tend to be more common in children than in adults.

Pyoderma gangrenosum (PG) is a chronic, recurrent condition characterized by cutaneous ulceration. In half of patients, PG is associated with an underlying illness, such as inflammatory bowel disease, RA, SLE, or a lymphoproliferative disorder.

ABSTRACT: The cardinal feature of irritable bowel syndrome (IBS) is abdominal pain or discomfort associated with altered bowel habits. Because no serologic marker or structural abnormality exists, the diagnosis is based on clinical findings. A systematic symptom-based approach, including the Rome II criteria, ensures diagnostic accuracy. Determine whether a specific event-such as gastroenteritis, antibiotic use, or a food-borne illness-precipitated the IBS symptoms. Be alert for warning signs of cancer, infection, or inflammatory bowel disease, such as fever or unexplained weight loss. Only minimal laboratory testing is required; however, further evaluation may be warranted if a patient does not respond to treatment or loses weight, if the dominant symptom changes, or if other "red flags" are identified.

Adhesions (A) can form within theperitoneal cavity after abdominalsurgery, especially if there is an underlyinginflammatory condition suchas appendicitis (B) or inflammatorybowel disease. The incidence of adhesiveintestinal obstruction following alaparotomy is approximately 2%. Mostadhesive obstructions occur within 3months of the laparotomy, and 80%occur within 2 years. Adhesive obstructionstend to be more commonin children than in adults.